Azur acquires anti-psychotic drug FazaClo

Pharmaceutical company Azur Pharma has acquired the anti-psychotic drug FazaClo from US company Avanir Pharmaceuticals.

Azur acquires anti-psychotic drug FazaClo

Pharmaceutical company Azur Pharma has acquired the anti-psychotic drug FazaClo from US company Avanir Pharmaceuticals.

Azur was established in June 2005 by former Elan senior executive Seamus Mulligan.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited